Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols.
Alexander M PopovBarbara BuldiniPaola De LorenzoSilvia DisaròTatiana VerzhbitskayaLiudmila MovchanEmanuela GiarinEgor ShorikovAnnamaria Di MeglioGrigory A TsaurRosanna ParasoleNatalia MiakovaElmira BoichenkoKonstantin KondratchikOlga AleinikovaAlexander KarachunskiyAlexander RoumiantsevFranco LocatelliAndrea BiondiRob PietersMaria Grazia ValsecchiLarisa FechinaGiuseppe BassoPublished in: Leukemia (2020)